Author:
De Meerleer Gert O.,Ost Piet,Villeirs Geert M.,Lumen Nicolaas,Fonteyne Valérie
Reference108 articles.
1. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007;178(3 Pt 2):S14–9.
2. D’Amico AV. Combined-modality staging for localized adenocarcinoma of the prostate. Oncology (Williston Park). 2001;15(8):1049–59; discussion 60–2, 64–5, 69–70, 73–5.
3. Scherr D, Swindle PW, Scardino PT. National comprehensive cancer network guidelines for the management of prostate cancer. Urology. 2003;61(2 Suppl 1):14–24.
4. Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98(10):715–7.
5. Diblasio CJ, Kattan MW. Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology. 2003;62 Suppl 1:9–18.